1 row is stored for this page
Field Field type Value generic String Memantine brand String Namenda (IR), Namenda XR (extended-release), Namzaric (with donepezil) structure File classes List of String , delimiter: , [[:Category:Anti-dementia medicines|Anti-dementia medicine]] • [[:Category:NMDA receptor antagonists|NMDA receptor antagonist (uncompetitive • low-affinity)]] • [[:Category:Adamantanes|Adamantane derivative]] mechanism String uses String '"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"' starting_dose String 5 mg PO once daily; titrate by 5 mg weekly to target 10 mg PO BID. XR formulation: 7 mg/day, titrate to 28 mg/day preparations String IR tablets 5, 10 mg; oral solution 2 mg/mL; XR capsules 7, 14, 21, 28 mg fda_max String 20 mg/day (IR); 28 mg/day (XR) pill_id Text routes List of String , delimiter: , Oral onset String Cognitive effect emerges gradually over weeks to months; symptomatic effect only duration String BID dosing for IR; once-daily for XR halflife String 60-100 hours (long)'"`UNIQ--ref-0000001B-QINU`"' bioavailability String ~100% (oral)'"`UNIQ--ref-0000001C-QINU`"' pregnancy String Limited human data; rarely indicated in pregnancy given the patient population.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> legal String [[USLegal:Prescription only|Rx-only]] in US
